Aurora Cannabis (ACB) Interest & Investment Income (2017 - 2026)
Aurora Cannabis (ACB) posted quarterly Interest & Investment Income of $758373.9 for Q1 2026, down 22.22% year-on-year from $974986.2 in Q1 2025, and up 6.72% on a QoQ basis from $710632.5 in Q4 2025.
Aurora Cannabis (ACB) Interest & Investment Income (2017 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Interest & Investment Income for 10 consecutive years, with $758373.9 the latest figure, recorded in Q1 2026.
- Quarterly Interest & Investment Income fell 22.22% year-over-year to $758373.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 43.26% YoY) and the FY2026 annual result came in at $4.2 million, down 42.98% from the prior year.
- Interest & Investment Income climbed to $758373.9 in Q1 2026 per ACB's latest filing, from $710632.5 in the prior quarter.
- Over the last five years, Interest & Investment Income for ACB reached as high as $6.6 million in Q4 2022 and fell as low as $519233.5 in Q2 2022.
- A 5-year average of $2.0 million and a median of $1.9 million in 2024 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income soared 912.05% — and 2023, when it tumbled 62.9%.
- Year by year, Interest & Investment Income stood at $6.6 million in 2022, then slumped by 62.9% to $2.4 million in 2023, then dropped by 23.83% to $1.9 million in 2024, then tumbled by 61.83% to $710632.5 in 2025, then grew by 6.72% to $758373.9 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $758373.9, $710632.5, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 32.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 41.80 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 28.10 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Aurora Cannabis | 155.40 Mn | 70.15 Mn | 21.72 Mn | 758,373.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 758,373.92 |
| Dec 31, 2025 | 710,632.51 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Mar 31, 2025 | 974,986.15 |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 2.44 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Dec 31, 2022 | 6.59 Mn |
| Sep 30, 2022 | 3.63 Mn |
| Jun 30, 2022 | 519,233.51 |
| Mar 31, 2022 | 738,159.50 |
| Dec 31, 2021 | 1.95 Mn |
| Sep 30, 2021 | 358,278.60 |
| Jun 30, 2021 | -1.05 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 1.43 Mn |